DEHP-free deal
This article was originally published in The Gray Sheet
Executive Summary
B. Braun Medical inked a five-year, $70 mil. supply contract with San Francisco-based hospital system Catholic Healthcare West for di-2-ethylhexyl phthalate (DEHP)-free IV bags, solutions and tubing, the firm announces Nov. 21. B. Braun is billing the deal as the first to validate its strategy of offering a full line of IV products free of the polyvinyl chloride softening agent. Some research suggests that devices containing the material might cause adverse effects on reproductive development when used on neonates and pregnant women (1"The Gray Sheet" Sept. 12, 2005, p. 7)...
You may also be interested in...
New Business Opportunities For DEHP-Free Products? B Braun Thinks So
Intravenous delivery product manufacturer B Braun is looking to gain market advantage based on what it sees as mounting recognition of the potential dangers of DEHP - a material that has been used in the manufacture of hospital equipment for decades
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.